NCT05233553View on ClinicalTrials.gov

SSC-COVID in Patients After COVID-19

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

January 31, 2022

Conditions
Secondary Sclerosing CholangitisCOVID-19
Interventions
OTHER

control of liver enzymes

follow-up with clinical and laboratory measurements

Trial Locations (1)

72076

University Hospital of Tuebingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT05233553 - SSC-COVID in Patients After COVID-19 | Biotech Hunter | Biotech Hunter